NeuroImage: Clinical (Jan 2022)

A resting-state fMRI pattern of spinocerebellar ataxia type 3 and comparison with 18F-FDG PET

  • Harm J. van der Horn,
  • Sanne K. Meles,
  • Jelmer G. Kok,
  • Victor M. Vergara,
  • Shile Qi,
  • Vince D. Calhoun,
  • Jelle R. Dalenberg,
  • Jeroen C.W. Siero,
  • Remco J. Renken,
  • Jeroen J. de Vries,
  • Jacoba M. Spikman,
  • Hubertus P.H. Kremer,
  • Bauke M. De Jong

Journal volume & issue
Vol. 34
p. 103023

Abstract

Read online

Spinocerebellar ataxia type 3 (SCA3) is a rare genetic neurodegenerative disease. The neurobiological basis of SCA3 is still poorly understood, and up until now resting-state fMRI (rs-fMRI) has not been used to study this disease. In the current study we investigated (multi-echo) rs-fMRI data from patients with genetically confirmed SCA3 (n = 17) and matched healthy subjects (n = 16). Using independent component analysis (ICA) and subsequent regression with bootstrap resampling, we identified a pattern of differences between patients and healthy subjects, which we coined the fMRI SCA3 related pattern (fSCA3-RP) comprising cerebellum, anterior striatum and various cortical regions. Individual fSCA3-RP scores were highly correlated with a previously published 18F-FDG PET pattern found in the same sample (rho = 0.78, P = 0.0003). Also, a high correlation was found with the Scale for Assessment and Rating of Ataxia scores (r = 0.63, P = 0.007). No correlations were found with neuropsychological test scores, nor with levels of grey matter atrophy. Compared with the 18F-FDG PET pattern, the fSCA3-RP included a more extensive contribution of the mediofrontal cortex, putatively representing changes in default network activity. This rs-fMRI identification of additional regions is proposed to reflect a consequence of the nature of the BOLD technique, enabling measurement of dynamic network activity, compared to the more static 18F-FDG PET methodology. Altogether, our findings shed new light on the neural substrate of SCA3, and encourage further validation of the fSCA3-RP to assess its potential contribution as imaging biomarker for future research and clinical use.

Keywords